Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00456612 · ClinicalTrials.gov registry record · Phase 1

Radiosurgery for Glioblastoma Multiforme

A Phase 1 study, sponsored by Beth Israel Deaconess Medical Center.

Terminated
Registry status
Phase 1
Development phase
4
Enrollment target

NCT00456612: Clinical Trial Phase 1 study, sponsored by Beth Israel Deaconess Medical Center.

NCT00456612 is a Phase 1 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00456612, a Phase 1 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.

TERMINATED
Registry status
Phase 1
Development phase
4 participants
Enrollment target

Study Summary

Conventional radiation for 6 weeks is not well tolerated by the elderly. Shorter courses (over 3-5 weeks) of radiation have been shown to be equivalent in outcome the elderly- particularly in patients who are generally in poor performance status (KPS\<70). Fractionated Cyberknife Radiosurgery can deliver equivalent doses in 5 treatments providing the same tumor control in a much shorter and tolerable schedule improving their quality of their short life. To assess the tolerability of Cyberknife Radiosurgery for High Grade Gliomas in Elderly with poor performance status. Secondary: Assessment of local control rate, progression free survival, overall survival, quality of life and toxicity and steroid dependence in this population with this regime.

Interventions

  • PROCEDURE CyberKnife

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2007-02
Est. Completion 2010-12
Phase Phase 1

Why NCT00456612 stopped before completion

NCT00456612 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which CyberKnife is the first listed.

NCT00456612 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00456612 about?

NCT00456612 is a clinical study titled "Radiosurgery for Glioblastoma Multiforme". Conventional radiation for 6 weeks is not well tolerated by the elderly. Shorter courses (over 3-5 weeks) of radiation have been shown to be equivalent in outcome the elderly- particularly in patients who are generally in poor performance status (KPS\<70). Fractionated Cyberknife Radiosurgery can de...

What is the current status of trial NCT00456612?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2007-02. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00456612?

The interventions under investigation include: CyberKnife (PROCEDURE).

Who is sponsoring clinical trial NCT00456612?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00456612's enrollment target sits among peer trials

4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00456612, the US trial registry maintained by the National Library of Medicine. NCT00456612 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.